From the Journals
To engage injection drug users in HCV care, go to where they are
News
Postpartum HCV treatment rare in infected mothers with opioid use disorder
While HCV screening and diagnosis rates varied across states, postpartum follow-up rates were universally low.
From the Journals
Combo DAA treatments may benefit patients with resistant HCV genotype 3
A variety of combo drug treatments proved effective in treating HCV genotype 3 to achieve sustained virologic response.
From the Journals
HCV screening risk factors in pregnant women need updating
Large study of pregnant women highlights the potential value of universal screening for hepatitis C virus.
News
Expert: Eliminating HCV ‘sounds ambitious, but I think it’s possible’
An estimated one in three inmates in the United States has chronic HCV.
News
FDA approves weekly contraceptive patch Twirla
The levonorgestrel and ethinyl estradiol contraceptive is contraindicated in obese women.
From the Journals
HCV testing/awareness successful as part of HIV integrated care
From the Journals
Rare mixed HCV genotypes found in men who have sex with men
From the Journals
Direct-acting antiviral therapy boosts survival for infected HCC patients
Adults with a history of hepatocellular carcinoma had a significantly reduced risk of death after treatment of HCV infections with DAAs.
From the Journals
Patients with viral hepatitis are living longer, increasing risk of extrahepatic mortality
In sharp contrast with the viral hepatitis findings, mortality rates among patients with ALD and NAFLD have increased.
From the Journals
Spleen/liver stiffness ratio differentiates HCV, ALD
The SS/LS ratio is significantly higher in patients with HCV than in those with alcohol-related liver disease (ALD).
News
Louisiana HCV program cuts costs – and hassles
No prior authorization will be necessary for a specific combination of direct-acting antiviral agents starting July 15.
From the Journals
Despite HCV cure, liver cancer-associated genetic changes persist
Conference Coverage
HCV treatment with DAA regimens linked to reduced diabetes risk
Diabetes incidence was lower in hepatitis C patients treated with DAAs than in untreated patients.